Canada: Fewer HIV Patients Becoming Drug-Resistant -- B.C. Study
January 26, 2010
A new study by researchers at the British Columbia Center for Excellence in HIV/AIDS shows a sharp drop in the prevalence of drug-resistant HIV among B.C. patients. From 1996 to 2008, drug resistance fell by more than 12-fold among the 5,422 patients involved in the longitudinal study.
"In the early days, people would have to take 30 pills a day," Harrigan said. "Now it's often just one pill a day."
"The main thing that we saw is that the [highly active antiretroviral therapies] are becoming more successful every year in keeping the level of virus in patients down below the level we can even detect," Harrigan said. "That prevents the virus from replicating, from making copies of itself and the disease doesn't progress," and it ensures fewer transmissions of resistant HIV, he said.
"Our results suggest an increasing effectiveness of highly active antiretroviral therapy at the population level," the authors concluded. "The vast majority of treated patients in British Columbia now have either suppressed plasma viral load or drug-susceptible HIV-1, according to their most recent study results."
The full study, "Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection," was published in Clinical Infectious Diseases (2010;50(1):98-105).
01.10.2010; Denise Ryan
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.